CM512

· Keymed Biosciences Co.Ltd

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CM512, covering 2025-04-16 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2） [Phase 2]